Cathie Wood Is Selling These 10 Stocks
There are few institutional investors who are willing to take risks on high growth stocks because of the price volatility and the nature of the business where innovation rules the day.
Biondvax Pharmaceuticals Ltd. (BVXV)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 230,896 | $137,475 | -37% | 0% |
| 2. | Sabby Capital Hal Mintz | 220,663 | $131,383 | -10% | 0.13% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,314 | $3,079 | 0% | |
| 2. | 2,582 | $1,538 | 0% | |
| 3. | 2,117 | $1,260 | 0% | |
| 4. | 424 | $252 | 0% | |
| 5. | 160 | $95 | 0% |
News See All
BiondVax Pharmaceuticals Ltd. (BVXV): Hedge Funds Are Snapping Up
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).